Nanoparticulate drug delivery: perspectives on the transition from laboratory to market
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Oxford
Woodhead Pub.
2012
|
| Schriftenreihe: | Woodhead Publishing series in biomedicine
no. 17 |
| Schlagworte: | |
| Online-Zugang: | FAW01 Volltext |
| Beschreibung: | Includes bibliographical references and index Nanotechnology-based therapeutics, operating at scales of billionths of a metre, have great potential for future expansion in altering the scale and methods of drug delivery. The availability of these novel formulations to once-inaccessible areas of the body has greatly expanded the therapeutic window of existing drug molecules. Nanoparticulate drug delivery highlights and examines the transition of nanoparticulate drug delivery systems from the laboratory into a commercially viable sector. The first chapters of the book provide an overview of the use and characterization of nanoparticulate systems as drug carriers, including the assessment of their morphology, sterility and potential toxicity. In the latter part of the book, chapters cover nanotoxicology, regulatory aspect and clinical trials, ending with an overview of several case studies and a look towards future developments. Discusses the issues surrounding nanoparticulate products, based on personal experience of their formulationProvides an overview of new application areas, including RNA interferenceOutlines the pros and cons of nanoparticulate products, and discusses how these may influence their route into the commercial sector |
| Beschreibung: | xiv, 229 pages |
| ISBN: | 1908818190 9781908818195 9781628703825 1628703822 9781907568985 1907568980 |
| ISSN: | 2050-0289 |
Internformat
MARC
| LEADER | 00000nmm a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV044388398 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 170630s2012 |||| o||u| ||||||eng d | ||
| 020 | |a 1908818190 |9 1-908818-19-0 | ||
| 020 | |a 9781908818195 |9 978-1-908818-19-5 | ||
| 020 | |a 9781628703825 |9 978-1-62870-382-5 | ||
| 020 | |a 1628703822 |9 1-62870-382-2 | ||
| 020 | |a 9781907568985 |9 978-1-907568-98-5 | ||
| 020 | |a 1907568980 |9 1-907568-98-0 | ||
| 035 | |a (ZDB-33-ESD)ocn826855524 | ||
| 035 | |a (OCoLC)826855524 | ||
| 035 | |a (DE-599)BVBBV044388398 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-1046 | ||
| 082 | 0 | |a 615.6 |2 23 | |
| 100 | 1 | |a Patravale, Vandana |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Nanoparticulate drug delivery |b perspectives on the transition from laboratory to market |c Vandana Patravale, Prajakta Dandekar and Ratnesh Jain |
| 264 | 1 | |a Oxford |b Woodhead Pub. |c 2012 | |
| 300 | |a xiv, 229 pages | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Woodhead Publishing series in biomedicine |v no. 17 |x 2050-0289 | |
| 500 | |a Includes bibliographical references and index | ||
| 500 | |a Nanotechnology-based therapeutics, operating at scales of billionths of a metre, have great potential for future expansion in altering the scale and methods of drug delivery. The availability of these novel formulations to once-inaccessible areas of the body has greatly expanded the therapeutic window of existing drug molecules. Nanoparticulate drug delivery highlights and examines the transition of nanoparticulate drug delivery systems from the laboratory into a commercially viable sector. The first chapters of the book provide an overview of the use and characterization of nanoparticulate systems as drug carriers, including the assessment of their morphology, sterility and potential toxicity. In the latter part of the book, chapters cover nanotoxicology, regulatory aspect and clinical trials, ending with an overview of several case studies and a look towards future developments. Discusses the issues surrounding nanoparticulate products, based on personal experience of their formulationProvides an overview of new application areas, including RNA interferenceOutlines the pros and cons of nanoparticulate products, and discusses how these may influence their route into the commercial sector | ||
| 650 | 4 | |a Drug Carriers | |
| 650 | 4 | |a Drug Delivery Systems / methods | |
| 650 | 4 | |a Drug delivery systems | |
| 650 | 4 | |a Nanoparticles | |
| 650 | 7 | |a MEDICAL / Pharmacology |2 bisacsh | |
| 650 | 7 | |a Drug delivery systems |2 fast | |
| 650 | 7 | |a Nanoparticles |2 fast | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Drug delivery systems | |
| 650 | 4 | |a Nanoparticles | |
| 700 | 1 | |a Dandekar, Prajakta |e Sonstige |4 oth | |
| 700 | 1 | |a Jain, Ratnesh |e Sonstige |4 oth | |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/book/9781907568985 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-33-ESD |a ZDB-33-EBS | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-029790619 | ||
| 966 | e | |u http://www.sciencedirect.com/science/book/9781907568985 |l FAW01 |p ZDB-33-ESD |q FAW_PDA_ESD |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804177658518437888 |
|---|---|
| any_adam_object | |
| author | Patravale, Vandana |
| author_facet | Patravale, Vandana |
| author_role | aut |
| author_sort | Patravale, Vandana |
| author_variant | v p vp |
| building | Verbundindex |
| bvnumber | BV044388398 |
| collection | ZDB-33-ESD ZDB-33-EBS |
| ctrlnum | (ZDB-33-ESD)ocn826855524 (OCoLC)826855524 (DE-599)BVBBV044388398 |
| dewey-full | 615.6 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615.6 |
| dewey-search | 615.6 |
| dewey-sort | 3615.6 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03203nmm a2200553zcb4500</leader><controlfield tag="001">BV044388398</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">170630s2012 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1908818190</subfield><subfield code="9">1-908818-19-0</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781908818195</subfield><subfield code="9">978-1-908818-19-5</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781628703825</subfield><subfield code="9">978-1-62870-382-5</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1628703822</subfield><subfield code="9">1-62870-382-2</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781907568985</subfield><subfield code="9">978-1-907568-98-5</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1907568980</subfield><subfield code="9">1-907568-98-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-33-ESD)ocn826855524</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)826855524</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044388398</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.6</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Patravale, Vandana</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Nanoparticulate drug delivery</subfield><subfield code="b">perspectives on the transition from laboratory to market</subfield><subfield code="c">Vandana Patravale, Prajakta Dandekar and Ratnesh Jain</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Oxford</subfield><subfield code="b">Woodhead Pub.</subfield><subfield code="c">2012</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xiv, 229 pages</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Woodhead Publishing series in biomedicine</subfield><subfield code="v">no. 17</subfield><subfield code="x">2050-0289</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Nanotechnology-based therapeutics, operating at scales of billionths of a metre, have great potential for future expansion in altering the scale and methods of drug delivery. The availability of these novel formulations to once-inaccessible areas of the body has greatly expanded the therapeutic window of existing drug molecules. Nanoparticulate drug delivery highlights and examines the transition of nanoparticulate drug delivery systems from the laboratory into a commercially viable sector. The first chapters of the book provide an overview of the use and characterization of nanoparticulate systems as drug carriers, including the assessment of their morphology, sterility and potential toxicity. In the latter part of the book, chapters cover nanotoxicology, regulatory aspect and clinical trials, ending with an overview of several case studies and a look towards future developments. Discusses the issues surrounding nanoparticulate products, based on personal experience of their formulationProvides an overview of new application areas, including RNA interferenceOutlines the pros and cons of nanoparticulate products, and discusses how these may influence their route into the commercial sector</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Carriers</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Delivery Systems / methods</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug delivery systems</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nanoparticles</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Pharmacology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drug delivery systems</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Nanoparticles</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug delivery systems</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nanoparticles</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dandekar, Prajakta</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jain, Ratnesh</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.sciencedirect.com/science/book/9781907568985</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-33-ESD</subfield><subfield code="a">ZDB-33-EBS</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029790619</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://www.sciencedirect.com/science/book/9781907568985</subfield><subfield code="l">FAW01</subfield><subfield code="p">ZDB-33-ESD</subfield><subfield code="q">FAW_PDA_ESD</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV044388398 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:51:35Z |
| institution | BVB |
| isbn | 1908818190 9781908818195 9781628703825 1628703822 9781907568985 1907568980 |
| issn | 2050-0289 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029790619 |
| oclc_num | 826855524 |
| open_access_boolean | |
| owner | DE-1046 |
| owner_facet | DE-1046 |
| physical | xiv, 229 pages |
| psigel | ZDB-33-ESD ZDB-33-EBS ZDB-33-ESD FAW_PDA_ESD |
| publishDate | 2012 |
| publishDateSearch | 2012 |
| publishDateSort | 2012 |
| publisher | Woodhead Pub. |
| record_format | marc |
| series2 | Woodhead Publishing series in biomedicine |
| spelling | Patravale, Vandana Verfasser aut Nanoparticulate drug delivery perspectives on the transition from laboratory to market Vandana Patravale, Prajakta Dandekar and Ratnesh Jain Oxford Woodhead Pub. 2012 xiv, 229 pages txt rdacontent c rdamedia cr rdacarrier Woodhead Publishing series in biomedicine no. 17 2050-0289 Includes bibliographical references and index Nanotechnology-based therapeutics, operating at scales of billionths of a metre, have great potential for future expansion in altering the scale and methods of drug delivery. The availability of these novel formulations to once-inaccessible areas of the body has greatly expanded the therapeutic window of existing drug molecules. Nanoparticulate drug delivery highlights and examines the transition of nanoparticulate drug delivery systems from the laboratory into a commercially viable sector. The first chapters of the book provide an overview of the use and characterization of nanoparticulate systems as drug carriers, including the assessment of their morphology, sterility and potential toxicity. In the latter part of the book, chapters cover nanotoxicology, regulatory aspect and clinical trials, ending with an overview of several case studies and a look towards future developments. Discusses the issues surrounding nanoparticulate products, based on personal experience of their formulationProvides an overview of new application areas, including RNA interferenceOutlines the pros and cons of nanoparticulate products, and discusses how these may influence their route into the commercial sector Drug Carriers Drug Delivery Systems / methods Drug delivery systems Nanoparticles MEDICAL / Pharmacology bisacsh Drug delivery systems fast Nanoparticles fast Medizin Dandekar, Prajakta Sonstige oth Jain, Ratnesh Sonstige oth http://www.sciencedirect.com/science/book/9781907568985 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Patravale, Vandana Nanoparticulate drug delivery perspectives on the transition from laboratory to market Drug Carriers Drug Delivery Systems / methods Drug delivery systems Nanoparticles MEDICAL / Pharmacology bisacsh Drug delivery systems fast Nanoparticles fast Medizin |
| title | Nanoparticulate drug delivery perspectives on the transition from laboratory to market |
| title_auth | Nanoparticulate drug delivery perspectives on the transition from laboratory to market |
| title_exact_search | Nanoparticulate drug delivery perspectives on the transition from laboratory to market |
| title_full | Nanoparticulate drug delivery perspectives on the transition from laboratory to market Vandana Patravale, Prajakta Dandekar and Ratnesh Jain |
| title_fullStr | Nanoparticulate drug delivery perspectives on the transition from laboratory to market Vandana Patravale, Prajakta Dandekar and Ratnesh Jain |
| title_full_unstemmed | Nanoparticulate drug delivery perspectives on the transition from laboratory to market Vandana Patravale, Prajakta Dandekar and Ratnesh Jain |
| title_short | Nanoparticulate drug delivery |
| title_sort | nanoparticulate drug delivery perspectives on the transition from laboratory to market |
| title_sub | perspectives on the transition from laboratory to market |
| topic | Drug Carriers Drug Delivery Systems / methods Drug delivery systems Nanoparticles MEDICAL / Pharmacology bisacsh Drug delivery systems fast Nanoparticles fast Medizin |
| topic_facet | Drug Carriers Drug Delivery Systems / methods Drug delivery systems Nanoparticles MEDICAL / Pharmacology Medizin |
| url | http://www.sciencedirect.com/science/book/9781907568985 |
| work_keys_str_mv | AT patravalevandana nanoparticulatedrugdeliveryperspectivesonthetransitionfromlaboratorytomarket AT dandekarprajakta nanoparticulatedrugdeliveryperspectivesonthetransitionfromlaboratorytomarket AT jainratnesh nanoparticulatedrugdeliveryperspectivesonthetransitionfromlaboratorytomarket |